ODTX is Odyssey Therapeutics, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $28.76. Market cap: $1.38B.
Stock snapshot
| Price | $28.76 |
| Market cap | $1.38B |
| Sector | Healthcare |
| Exchange | NCM |
| Pays dividend | No |
About ODTX
Odyssey Therapeutics Inc is a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases. The Company is developing medicines that are designed to precisely target disease pathology with an initial emphasis on the innate immune system. Its programs include OD-07656, a small molecule scaffolding inhibitor of receptor-interacting protein kinase 2, or RIPK2, a small molecule scaffolding inhibitor of interleukin-1 receptor-associated kinase 4, or IRAK4, and OD-00910, an agonistic protein therapeutic targeting tumor necrosis factor receptor 2, or TNFR2, built from camelid heavy chain variable regions, or VHH, domains.
Related non-dividend companies
Other non-dividend stocks investors research alongside ODTX. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is ODTX's current stock price?
ODTX (Odyssey Therapeutics, Inc.) is currently trading at $28.76.
Does ODTX pay a dividend?
ODTX (Odyssey Therapeutics, Inc.) does not currently pay a regular dividend.
Track ODTX in DiviDrip
Add ODTX to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search ODTX and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-05. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.